Cappuccino mutation in an autoimmune-prone strain of mice suggests a role of platelet function in the progression of immune complex crescentic glomerulonephritis.
暂无分享,去创建一个
Shoko Iwaki | M. Ono | M. Nose | K. Maeyama | T. Niiya | H. Furukawa | H. Komori | N. Arita | T. Hato | T. Tsubaki | M. Terada | Minako Yoshida | K. Saiga | K. Nemoto
[1] W. Clark,et al. Intrarenal platelet consumption in the diffuse proliferative nephritis of systemic lupus erythematosus. , 1975, Clinical science and molecular medicine.
[2] T. Yoshino,et al. Modulation of Immunoglobulin (Ig)E-mediated Systemic Anaphylaxis by Low-Affinity Fc Receptors for IgG , 1999, The Journal of experimental medicine.
[3] John D Lambris,et al. C5a promotes development of experimental lupus nephritis which can be blocked with a specific receptor antagonist , 2005, European journal of immunology.
[4] B. Ryffel,et al. Prevention of crescentic glomerulonephritis induced by anti-glomerular membrane antibody in tumor necrosis factor-deficient mice. , 1998, Laboratory investigation; a journal of technical methods and pathology.
[5] E. C. Dell'Angelica,et al. Identification of Snapin and Three Novel Proteins (BLOS1, BLOS2, and BLOS3/Reduced Pigmentation) as Subunits of Biogenesis of Lysosome-related Organelles Complex-1 (BLOC-1)* , 2004, Journal of Biological Chemistry.
[6] K. Matsushima,et al. A new anti-inflammatory compound, FR167653, ameliorates crescentic glomerulonephritis in Wistar-Kyoto rats. , 2000, Journal of the American Society of Nephrology : JASN.
[7] Y. Suzuki,et al. Effect of DP-1904, a thromboxane A2 synthase inhibitor, administered from the autologous phase on crescentic-type anti-GBM nephritis in rats. , 1995, Japanese journal of pharmacology.
[8] H. Avenarius,et al. Thrombozytenfunktion und Thrombozyten-assoziierte Immunglobuline bei Patienten mit systemischem Lupus erythematodes und chronischer Polyarthritis , 1990, Klinische Wochenschrift.
[9] P. Tipping,et al. IL‐12 directs severe renal injury, crescent formation and Th1 responses in murine glomerulonephritis , 1999, European journal of immunology.
[10] S. Fujita,et al. Antagonist of fractalkine (CX3CL1) delays the initiation and ameliorates the progression of lupus nephritis in MRL/lpr mice. , 2005, Arthritis and rheumatism.
[11] P. Ronco,et al. Role of matrix metalloproteinases in kidney development and glomerulopathy: lessons from transgenic mice. , 2002, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[12] J. Meyerhoff,et al. Decreased platelet serotonin levels in systemic lupus erythematosus. , 1981, Arthritis and rheumatism.
[13] H. Watanabe,et al. Mice with early onset of death (EOD) due to lupus glomerulonephritis , 1999, Clinical and experimental immunology.
[14] T. Shirakawa,et al. Blockade of TGF-beta action ameliorates renal dysfunction and histologic progression in anti-GBM nephritis. , 2003, Kidney international.
[15] J. Bonifacino,et al. Reduced pigmentation (rp), a mouse model of Hermansky-Pudlak syndrome, encodes a novel component of the BLOC-1 complex. , 2004, Blood.
[16] C. Pusey,et al. Antibody blockade of TNF-alpha reduces inflammation and scarring in experimental crescentic glomerulonephritis. , 2005, Kidney international.
[17] P. Carmeliet,et al. Deficiency or inhibition of Gas6 causes platelet dysfunction and protects mice against thrombosis , 2001, Nature Medicine.
[18] J. Bonifacino,et al. Cappuccino, a mouse model of Hermansky-Pudlak syndrome, encodes a novel protein that is part of the pallidin-muted complex (BLOC-1). , 2003, Blood.
[19] Cameron Js. Glomerulonephritis: current problems and understanding. , 1982 .
[20] M. Ono,et al. Fcgamma receptor IIB-deficient mice develop Goodpasture's syndrome upon immunization with type IV collagen: a novel murine model for autoimmune glomerular basement membrane disease. , 2000, The Journal of experimental medicine.
[21] G. Frampton,et al. Platelet and plasma serotonin in glomerulonephritis. III: The nephritis of systemic lupus erythematosus. , 1980, Clinical nephrology.
[22] R. Atkins,et al. Interleukin-1 receptor antagonist halts the progression of established crescentic glomerulonephritis in the rat. , 1995, Kidney international.
[23] D. Salant,et al. Essential role of Gas6 for glomerular injury in nephrotoxic nephritis. , 2002, The Journal of clinical investigation.
[24] Y. Igarashi. Sarpogrelate, a serotonin receptor (5HT2ar) antagonist, ameliorates renal damage in experimental mesangial proliferative glomerulonephritis , 2000, Clinical and Experimental Nephrology.
[25] C. Kallenberg,et al. Expression of iNOS, eNOS, and peroxynitrite-modified proteins in experimental anti-myeloperoxidase associated crescentic glomerulonephritis. , 1996, Kidney international.
[26] S. Giannouli,et al. Lupus thrombocytopenia: clinical implications and prognostic significance , 2005, Annals of the rheumatic diseases.
[27] J. Bonifacino,et al. Defects in the cappuccino (cno) gene on mouse chromosome 5 and human 4p cause Hermansky-Pudlak syndrome by an AP-3-independent mechanism. , 2000, Blood.
[28] Naoki Oiso,et al. Hermansky-Pudlak syndrome type 7 (HPS-7) results from mutant dysbindin, a member of the biogenesis of lysosome-related organelles complex 1 (BLOC-1) , 2003, Nature Genetics.
[29] R. Swank,et al. Cocoa: a new mouse model for platelet storage pool deficiency , 1988, British journal of haematology.
[30] M. Rashid,et al. Functions of 5-HT2A receptor and its antagonists in the cardiovascular system. , 2004, Pharmacology & therapeutics.
[31] R. Atkins,et al. Reversal of Established Rat Crescentic Glomerulonephritis by Blockade of Macrophage Migration Inhibitory Factor (MIF): Potential Role of MIF in Regulating Glucocorticoid Production , 1998, Molecular medicine.
[32] J. Miyazaki,et al. Antagonist of monocyte chemoattractant protein 1 ameliorates the initiation and progression of lupus nephritis and renal vasculitis in MRL/lpr mice. , 2003, Arthritis and rheumatism.
[33] I. Narita,et al. Macrophage Metalloelastase as a Major Factor for Glomerular Injury in Anti-Glomerular Basement Membrane Nephritis 1 , 2003, The Journal of Immunology.
[34] P. Tipping,et al. Interleukin-4 deficiency enhances Th1 responses and crescentic glomerulonephritis in mice. , 1998, Kidney international.
[35] G. Frampton,et al. Platelet and plasma serotonin concentrations in glomerulonephritis, II. , 1980, Clinical nephrology.
[36] Stephen Tomlinson,et al. Complement receptor 2-mediated targeting of complement inhibitors to sites of complement activation. , 2003, The Journal of clinical investigation.
[37] S. Israels,et al. Platelet dense granules: structure, function and implications for haemostasis. , 1999, Thrombosis research.
[38] J. Ravetch,et al. Uncoupling of immune complex formation and kidney damage in autoimmune glomerulonephritis. , 1998, Science.
[39] Lee Hebert,et al. The classification of glomerulonephritis in systemic lupus erythematosus revisited. , 2004, Journal of the American Society of Nephrology : JASN.
[40] M. Ono,et al. Bone marrow cell transfer of autoimmune diseases in a MRL strain of mice with a deficit in functional Fas ligand: Dissociation of arteritis from glomerulonephritis , 2003, Pathology international.
[41] J. Falcón-Pérez,et al. BLOC-1, a Novel Complex Containing the Pallidin and Muted Proteins Involved in the Biogenesis of Melanosomes and Platelet-dense Granules* , 2002, The Journal of Biological Chemistry.
[42] H. Hirakata,et al. Amelioration of autoimmune nephritis by imatinib in MRL/lpr mice. , 2005, Arthritis and rheumatism.
[43] W. Clark,et al. Immunologic findings, thrombocytopenia and disease activity in lupus nephritis. , 1978, Canadian Medical Association journal.
[44] K. Hiromura,et al. Role of serotonin in nephrotoxic serum nephritis in WKY rats. , 1997, The Journal of laboratory and clinical medicine.
[45] C. Heldin,et al. COULD PLATELET-DERIVED GROWTH FACTOR HAVE A ROLE IN THE PATHOGENESIS OF LUPUS NEPHRITIS? , 1988, The Lancet.
[46] P. Tipping,et al. IFN-γ Mediates Crescent Formation and Cell-Mediated Immune Injury in Murine Glomerulonephritis , 1999 .
[47] D. Witte,et al. Crescentic glomerulonephritis is diminished in fibrinogen-deficient mice. , 2001, American journal of physiology. Renal physiology.
[48] P. Tipping,et al. Contributions of IL-1β and IL-1α to Crescentic Glomerulonephritis in Mice , 2004 .
[49] F. Rendu,et al. The platelet release reaction: granules' constituents, secretion and functions , 2001, Platelets.